Entering China’s rapidly expanding pharmaceutical market is a significant opportunity, but navigating the NMPA's expectations, data requirements, and approval timelines can be challenging without a clear roadmap.

In this short explainer video, we simplify the 10 essential steps that take you from development to successful market entry without delays or uncertainty.

If you’re:

  • Unsure where to begin,
  • Struggling with China-specific data or clinical expectations, or
  • Concerned about long review cycles and complex submissions,

This guide breaks down the entire process into an easy-to-follow pathway for first-time entrants and global manufacturers expanding into China.

Watch our quick guide to see how Freyr makes the journey faster, compliant, and hassle-free.
Start watching now and connect with our experts to accelerate your China entry.